Reflecting a broader trend of Microsoft embracing Claude AI, recent VS Code updates show the company accommodating Claude Code beyond model selection, with support for Claude-specific instruction ...
TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
May 4, 2026 Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results